In today's data-rich environment, business are always looking for a way to capitalize on available data for new insights and ...

MMM isn't a replacement for all attribution, but it is a powerful strategic layer that can restore clarity to marketing ...

Shaji Kumar, MD, Mayo Clinic, discusses the July approval of linvoseltamab, a new bispecific antibody for relapsed myeloma, and how it expands treatment options for patients. He also emphasizes the ...